TNON Share Price Performance
US$1.35
-3.40 (-71.60%)
50.9% undervalued intrinsic discount
US$2.75
Fair Value
Price US$1.35
AnalystConsensusTarget US$2.75
Fair ValueUS$2.75
Share PriceUS$1.35
50.9% undervalued intrinsic discount
TNON Community Narratives
AN
Fair Value US$2.75 50.9% undervalued intrinsic discount
Our Catamaran SE Launch Will Drive SI Joint Adoption
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
Recent TNON News & Updates
No updates
Tenon Medical, Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 13, 2025
- Earnings per share (EPS)
- -1.81
- Gross Margin
- 47.62%
- Net Profit Margin
- -417.57%
- Debt/Equity Ratio
- 0%
Tenon Medical, Inc. Competitors
About TNON
- Founded
- 2012
- Employees
- 27
- CEO
- WebsiteView website
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
U.S. Market Performance
- 7 Days: 0.2%
- 3 Months: 12.2%
- 1 Year: 19.9%
- Year to Date: 7.6%
The Consumer Staples sector gained 3.2% while the market remained flat over the last week. As for the longer term, the market has risen 20% in the past 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading